Buck names new chairman

[caption id="attachment_46223" align="alignleft" width="235" caption="James Edgar"][/caption]

NOVATO --The board of trustees at the Buck Institute for Research and Aging appointed James Edgar as chairman, effective Jan. 1.

His appointment comes at a crucial time in the history of the Buck, officials said. The institute will open its new regenerative research building in April.

"The institute is poised to reach new heights, and it will be a privilege to work with our board, staff and scientists to ensure that the Buck succeeds in its mission to extend the healthy years of life," Mr. Edgar said in a statement."We will be adding outstanding new investigators to our faculty and launching programs that have global impact in the coming year. I look forward to supporting these outstanding efforts."

Mr. Edgar, who joined the board in 2007, has served as vice chairman and head of the board's development committee, which provides guidance on the institute's philanthropic and outreach efforts.

Mr. Edgar has been a management consultant for his entire professional life, specializing in competitive brand positioning, marketing strategy and organizational development. He is a founding member of Edgar, Dunn & Company, an international consulting firm with clients in 45 countries and offices in Atlanta, Frankfurt, London, San Francisco, Singapore and Sydney.

He has also served as chair of the San Francisco Chamber of Commerce, the Library Foundation of San Francisco and the Rosenberg Foundation. He was an executive committee member of the San Francisco Mayor's Fiscal Advisory Committee and served on the San Francisco Committee on Jobs. He is a current member of the Buck Advisory Council, which advances the institute's scientific and educational mission. He lives in Kentfield.

"We are fortunate to have Jim Edgar as chair," said Brian Kennedy, Ph.D., Buck president and chief executive officer. "His depth of knowledge of Institute activities, his contacts in the community and his commitment to our success will be invaluable as we build on the Institute's reputation as the nation's preeminent research facility on aging."

Show Comment